amniocentesis

Detecting abnormalities, documenting optionsA California woman was 35-years-old when she delivered an infant with severe Down's syndrome and then sued all those involved with the prenatal care and alleged that both physicians were told the parents wanted all available testing because of a family history of birth defects. What's the verdict? Plus more cases.
Clinician to Clinician: Reaffirming the role of lung maturity testing in the at-risk pregnancyKnowledge of fetal lung maturity provides useful adjunctive information that is unique and relevant to a patient.
Interactive tools may help patients make informed decisions about prenatal testsA computerized decision-support guide may help women make more informed choices about prenatal testing, according to results of a randomized trial published in JAMA. The findings, which require validation in other populations, suggest that, were women better educated about the technology, fewer prenatal tests would be done.
Cell-free DNA testing: Preferred for detection of fetal aneuploidy
Cell-free DNA testing: Preferred for detection of fetal aneuploidyInvasive prenatal diagnosis may soon be completely replaced by noninvasive assessment of maternal plasma cell-free DNA.
(PDF) SMFM Patient Handout: Risks of Chorionic Villus Sampling (CVS) and Amniocentesis(PDF) SMFM Patient Handout: Risks of Chorionic Villus Sampling (CVS) and Amniocentesis
SMFM Consult: Risks of chorionic villus sampling and amniocentesis
SMFM Consult: Risks of chorionic villus sampling and amniocentesisQuestions and answers about fetal loss and complications associated with chorionic villus sampling and amniocentesis.